<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: Ohio State University Medical Center in the news</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress provides the latest news from Ohio State University Medical Center</description>

 <item>
     <title>Expert explores how sunlight may affect ADHD patients</title>
   	 <description>Researchers are interested in exploring how sunlight, sleep and screens (like those on computers and TVs) may affect those with attention-deficit/hyperactivity disorder (ADHD), says Dr. L. Eugene Arnold, a child psychiatrist and ADHD expert at the Ohio State University Wexner Medical Center's Nisonger Center.</description>
     <link>http://medicalxpress.com/news/2013-05-expert-explores-sunlight-affect-adhd.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Fri, 17 May 2013 08:07:11 EST</pubDate>
	 <guid isPermaLink="false">news287996818</guid>
	 
</item>
<item>
     <title>Study identifies possible new acute leukemia marker, treatment target</title>
   	 <description>A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal acute myeloid leukemia, or CN-AML).</description>
     <link>http://medicalxpress.com/news/2013-05-acute-leukemia-marker-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 13 May 2013 16:49:07 EST</pubDate>
	 <guid isPermaLink="false">news287682539</guid>
	 
</item>
<item>
     <title>Big data analysis identifies prognostic RNA markers in a common form of breast cancer</title>
   	 <description>A Big Data analysis that integrates three large sets of genomic data available through The Cancer Genome Atlas has identified 37 RNA molecules that might predict survival in patients with the most common form of breast cancer.</description>
     <link>http://medicalxpress.com/news/2013-04-big-analysis-prognostic-rna-markers.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 29 Apr 2013 14:48:11 EST</pubDate>
	 <guid isPermaLink="false">news286465674</guid>
	 
</item>
<item>
     <title>New agent might control breast-cancer growth and spread</title>
   	 <description>A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs.</description>
     <link>http://medicalxpress.com/news/2013-04-agent-breast-cancer-growth.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 22 Apr 2013 09:50:01 EST</pubDate>
	 <guid isPermaLink="false">news285842034</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/newagentmigh.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers design drug to restore cell suicide in HPV-related head and neck cancer</title>
   	 <description>Researchers have discovered a new mechanism by which the human papilloma virus (HPV) causes head and neck cancer, and they have designed a drug to block that mechanism. Though further research is needed, the new agent might offer a safer treatment for these tumors when combined with a tapered dose of standard chemotherapy.</description>
     <link>http://medicalxpress.com/news/2013-04-drug-cell-suicide-hpv-related-neck.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 08 Apr 2013 12:32:08 EST</pubDate>
	 <guid isPermaLink="false">news284643120</guid>
	 
</item>
<item>
     <title>Informatics helps drive clinical and translational research</title>
   	 <description>According to researchers, clinical and translational science has emerged as a national priority and investigators are increasingly becoming reliant on the use of computer science (CS), information science (IS), biomedical informatics (BMI) and information technology (IT) tools and methods to support and enable high impact research.</description>
     <link>http://medicalxpress.com/news/2013-03-informatics-clinical.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 15 Mar 2013 06:44:56 EST</pubDate>
	 <guid isPermaLink="false">news282548643</guid>
	 
</item>
<item>
     <title>Small molecules in the blood might gauge radiation effects after exposure</title>
   	 <description>Ohio State University cancer researchers have identified molecules in the bloodstream that might accurately gauge the likelihood of radiation illness after exposure to ionizing radiation.</description>
     <link>http://medicalxpress.com/news/2013-02-small-molecules-blood-gauge-effects.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 25 Feb 2013 17:00:03 EST</pubDate>
	 <guid isPermaLink="false">news281010315</guid>
	 
</item>
<item>
     <title>Outdated 'paper chart' model of computerized provider documentation seen as problematic</title>
   	 <description>As healthcare practitioners and institutions increase their adoption and use of electronic health records, the transition from paper-based to computerized provider documentation (CPD) is having dramatic effects on a range of healthcare and business processes, and not all of them positive.</description>
     <link>http://medicalxpress.com/news/2013-02-outdated-paper-computerized-documentation-problematic.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 14 Feb 2013 09:30:01 EST</pubDate>
	 <guid isPermaLink="false">news280054708</guid>
	 
</item>
<item>
     <title>Triple-negative breast cancer subtypes identified using microRNA</title>
   	 <description>A new, large-scale study of triple-negative breast cancer shows that small molecules called microRNA can be used to define four subtypes of this aggressive malignancy.</description>
     <link>http://medicalxpress.com/news/2013-02-triple-negative-breast-cancer-subtypes-microrna.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 07 Feb 2013 17:06:14 EST</pubDate>
	 <guid isPermaLink="false">news279479136</guid>
	 
</item>
<item>
     <title>Survey finds folk remedies often offered during breastfeeding</title>
   	 <description>(Medical Xpress)—Breastfeeding can be a difficult time for both mother and baby, so using cabbage leaves and tea bags to ease pain or eating oatmeal to increase milk production are among the folk remedies that women pass along to new mothers seeking help.</description>
     <link>http://medicalxpress.com/news/2013-01-survey-folk-remedies-breastfeeding.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 21 Jan 2013 06:37:00 EST</pubDate>
	 <guid isPermaLink="false">news277972603</guid>
	 
</item>
<item>
     <title>Older and younger chronic leukemia patients may need different therapy</title>
   	 <description>Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).</description>
     <link>http://medicalxpress.com/news/2012-12-older-younger-chronic-leukemia-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 12 Dec 2012 12:05:51 EST</pubDate>
	 <guid isPermaLink="false">news274536342</guid>
	 
</item>
<item>
     <title>Reduced intensity regimen prior to marrow transplant better for older leukemia patients</title>
   	 <description>A new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that preparing older acute myeloid leukemia (AML) patients for bone marrow transplants with a reduced intensity conditioning regimen appears to be associated with higher rates of disease-free survival relative to the more typical treatments usually given to such patients. The study was presented at the 2012 American Society of Hematology (ASH) Annual Meeting in Atlanta, GA.</description>
     <link>http://medicalxpress.com/news/2012-12-intensity-regimen-prior-marrow-transplant_1.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 10 Dec 2012 00:00:01 EST</pubDate>
	 <guid isPermaLink="false">news274318904</guid>
	 
</item>
<item>
     <title>Updated clinical results show experimental agent ibrutinib as highly active in CLL patients</title>
   	 <description>Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.</description>
     <link>http://medicalxpress.com/news/2012-12-clinical-results-experimental-agent-ibrutinib.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 09 Dec 2012 03:00:17 EST</pubDate>
	 <guid isPermaLink="false">news274244403</guid>
	 
</item>
<item>
     <title>Patient's own immune cells may blunt viral therapy for brain cancer</title>
   	 <description>Doctors now use cancer-killing viruses to treat some patients with lethal, fast-growing brain tumors. Clinical trials show that these therapeutic viruses are safe but less effective than expected.</description>
     <link>http://medicalxpress.com/news/2012-11-patient-immune-cells-blunt-viral.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 25 Nov 2012 13:00:06 EST</pubDate>
	 <guid isPermaLink="false">news273067398</guid>
	 
</item>
<item>
     <title>Study shows how chronic inflammation can cause cancer</title>
   	 <description>A hormone-like substance produced by the body to promote inflammation can cause an aggressive form of leukemia when present at high levels, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).</description>
     <link>http://medicalxpress.com/news/2012-11-chronic-inflammation-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 12 Nov 2012 12:00:09 EST</pubDate>
	 <guid isPermaLink="false">news271941278</guid>
	 
</item>


</channel>
</rss>
